Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 9, 2020
Immunomodulatory dose of clindamycin in combination with ceftriaxone improves survival and prevents organ damage in murine polymicrobial sepsisAnasuya M Patel, Hariharan Periasamy, Santosh N Mokale
Antimicrobial Agents and Chemotherapy|July 4, 2018
Azithromycin in Combination with Ceftriaxone Reduces Systemic Inflammation and Provides Survival Benefit in a Murine Model of Polymicrobial SepsisAnasuya Patel, Jiji Joseph, Hariharan Periasamy, et al.
Inflammation|January 20, 2020
Immunomodulatory Effect of Doxycycline Ameliorates Systemic and Pulmonary Inflammation in a Murine Polymicrobial Sepsis ModelAnasuya Patel, Hemant Khande, Hariharan Periasamy, et al.
Antimicrobial Agents and Chemotherapy|March 4, 2020
Unorthodox Parenteral β-Lactam and β-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient CareSnehal Palwe, Balaji Veeraraghavan, Hariharan Periasamy, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2022
Cefepime pharmacodynamic targets against Enterobacterales employing neutropenic murine lung infection and in vitro pharmacokinetic modelsAnouk E Muller, Marie Attwood, Sanne Van den Berg, et al.
Infectious Diseases and Therapy|March 6, 2023
β-Lactam Resistance in ESKAPE Pathogens Mediated Through Modifications in Penicillin-Binding Proteins: An OverviewDhiviya Prabaa Muthuirulandi Sethuvel, Yamuna Devi Bakthavatchalam, Maruthan Karthik, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2019
In Vivo Pharmacokinetic/Pharmacodynamic Targets of Levonadifloxacin against Staphylococcus aureus in a Neutropenic Murine Lung Infection ModelSachin S Bhagwat, Hariharan Periasamy, Swapna S Takalkar, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2019
In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniaeBartolome Moya, Isabel M Barcelo, Gabriel Cabot, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2021
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitalsSachin S Bhagwat, Nicholas J Legakis, Tilemachos Skalidis, et al.
The Lancet Regional Health. Southeast Asia|October 6, 2025
Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trialHimanshu Pophale, Monica Gupta, Lily Llorens, et al.
Pageof 2